Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
How MariTide Could Change the Game for Weight Loss: A Comprehensive ...
Amgen says MariTide helped trial patients maintain weight loss | Reuters
Once-Monthly MariTide Shows Promise for Weight Loss
Amgen Wants MariTide To Change Obesity Paradigm With Longer Dosing ...
Astounding MariTide for Weight Loss: Monthly Injection Insights
Amgen's MariTide Showcases Significant Weight Loss in Phase II Study ...
MariTide vs Tirzepatide: Similarities and Differences
MariTide by Amgen Boosts Weight Loss Without a Plateau | Woman's World
What Does MariTide Do to Your Body? - NowPatient
Amgen MariTide
Ozempic Category Killer? MariTide Requires Less Frequent Doses Than ...
Amgen says obesity drug MariTide caused up to 20% weight loss after a year
Trial Scorecard: MariTide
Amgen Stock Dips After MariTide Fails to Top Weight Loss Leaders
Amgen's Maritide Shows Significant Weight Loss in Phase 2 Trial
When Is MariTide Expected to Launch?
Amgen's obesity drug: what you need to know about MariTide
Amgen gears up for phase 3 trial of monthly weight-loss drug MariTide ...
How Does MariTide Work?
Amgen (AMGN) Stock Climbs on MariTide Weight-Loss Drug Momentum - Parameter
Amgen's MariTide Enters Phase 3 Trials: A New Contender in Weight Loss ...
Один укол препарата MariTide от Amgen в месяц снижает вес на 16 ...
MariTide (maridebart cafraglutide): Mechanism, Trials, and Pipeline ...
MariTide Shows Up to 20% Weight Loss in Phase II Trial for Obesity ...
Amgen Reports Promising Phase 2 Data on MariTide for Obesity, Type 2 ...
Maritide (AMG 133): Research Profile, Mechanism & Protocols | PepGuide ...
Weight-Loss Drug MariTide Gains Momentum in Phase II Trial | tctmd.com
Maritide : vers une gestion du poids sans effets indésirables grâce à ...
20240506 Amgen maritide 安进 马里肽 GLP-1/GIP双靶点 博瑞医药 BGM0504 迎来超级利好 Amgen ...
Obesity Drug MariTide Achieves Up to 20% Weight Loss in Phase 2 Trial
Amgen's Next MariTide Update: What The Weight-Loss Drug Could Show ...
MariTide Induces Robust Weight Loss in Phase 2 Obesity Trial
MariTide Phase 3 Path After 20% Weight Loss
MariTide Molecular Structure and Properties | Peptide Protocol Wiki
Amgen Pushes Obesity Drug MariTide Forward, Reports 22% Q1 Revenue ...
Amgen Advances MariTide as a Potential Leading Monthly Obesity ...
Amgen's MariTide Challenges Weight Loss Drug Market with Innovative ...
Nuevo fármaco MariTide muestra resultados prometedores: hasta 16% de ...
Amgen axes an obesity asset, zooms in on MariTide
Amgen goes all in on injectable obesity treatment MariTide
MariTide
MariTide Side Effects and Safety Profile | Peptide Protocol Wiki
Can Amgen's MariTide Win Share in the Fast-Growing Obesity Market ...
MariTide Research Studies and Evidence | Peptide Protocol Wiki
Amgen’s MariTide Advances as a Promising Weight Loss Drug - GLP-1 Health
Development Progress and Prospects of Antibody-Peptide Conjugates
TidesPro | 双抗多肽偶联分子MariTide平均减重20% 2024-11-26 ，Amgen宣布了一项为期52周的治疗2型糖尿病和 ...
Twitchy Investors React to a Monthly Obesity Medicine - ConscienHealth
MariTide’s Weight Loss Milestone - Cardiac Wire
【NEJM 2025年掲載】開発中の薬剤Maritide（マリタイド）論文解説｜月1回投与で最大16%体重減少を実現した次世代肥満治療薬の全貌 ...
May 2024: The Ozempic Craze: In the Perspective of Antibody Drugs
Best-in-Class GLP-1 Drugs: Who Will Lead the Market? Viking or Amgen?
Experimental once-a-month weight loss injectable shows lasting results ...
Maridebart Cafraglutide|MariTide|AMG 133——药研档案
「次世代の減量薬」マリタイドが「二重の突破」を迎えることが期待される。アムジェン（AMGN.US）は、価値再評価の道を進んでいる。
Amgen Could Become A Real Contender In The Obesity Market (NASDAQ:AMGN ...
【药海听涛】拮抗还是干不过激动：Amgen公布减肥药MariTide二期数据 被全行业念叨了快一整年的GIPR拮抗与激动之争，总算是盼来了结果 ...
Amgen's MariTide: A Structural Shift in Obesity Pharmacotherapy
MariTide: Monthly Weight Loss Injection (Amgen 2026) | PeptideMark
安进公布「MariTide」II期临床试验积极结果：肥胖患者52周减重20%_摩熵医药
MariTide: Nuovo Farmaco Provato per la Perdita di Peso – Scienze Notizie
MariTide: Amgen's Experimental Obesity Drug Demonstrates Sustained ...
What to know about MariTide, Amgen’s experimental GLP-1 drug
What Is Amgen’s Drug MariTide? - NowPatient
安进减肥药效果亮眼但副作用较高，股价一度大跌超11% 11月26日， 安进 公布了备受关注的MariTide（maridebart ...
Maridebart cafraglutide (MariTide): once-monthly Phase 2 evidence ...
20% weight loss - MariTide” weight loss injection only once a month ...
MariTide: Promising Results & Challenges in Treatment Trials | QuickMD
Amgen Announces Promising Phase 2 Results for MariTide, Showing ...
The Story of Maridebart Cafraglutide (MariTide) | Amgen
MariTide: Complete Overview and Research Guide | Peptide Protocol Wiki
AMG-MariTide Phase2 Readout | PDF | Glycated Hemoglobin | Obesity
'Amgen' avanza con 'MariTide', un medicamento experimental para la ...
减重赛道“卷”出新高度！NEJM双刊登：一月一针MariTide VS 强效组合CagriSema，未来谁更能打？ - 方舟医聊
Amgen 肥胖藥 MariTide，顯著減重 20% - 財報狗
What Is MariTide?
MariTide: Was die monatliche Abnehmspritze von Amgen kann und was nicht ...
Inside Amgen’s Phase 3 MARITIME Program: Advancing the Future of ...
A Deeper Dive into MariTide: A Detailed Analysis of the Mechanism ...
MariTide: Amgen's Contender in the Obesity Drug Arena | Health
MariTide's Monthly Dosing Edge and Manufacturing Muscle Position Amgen ...
Amgen's MariTide: Promising Weight Loss with Milder Side Effects | Health
Understanding MariTide: A Drug Analysis by emine cifci on Prezi
Amgen enfrenta decepción en ensayo clínico de MariTide, su fármaco ...
Amgen's big reveal of obesity data falls a little flat | pharmaphorum
Revolution in Obesity: A Monthly Treatment Period with Two Effective ...
Eli Lilly Vs. Amgen: Who Leads Obesity And IMIDs (NASDAQ:AMGN ...
First trial of new monthly weight loss jab shows jaw-dropping results ...
MariTide, nytt läkemedel som ger långvarig viktnedgång - Diabetes Sverige
“下一代减肥药”MariTide有望迎“双面突破”! 安进迈向价值重估之路_腾讯新闻
Amgen e il successo di MariTide: un nuovo orizzonte nel trattamento ...
MariTide: Amgen's Monthly GLP-1 Shot Sets New Bar
What Is MariTide? A Once-Monthly Weight Loss Medication in Trials
Beyond Ozempic: The Next Generation of Metabolic Meds Hitting the ...
Alveus launches with $160M to advance MariTide-like obesity drug ...
超长效制剂中MariTide减重效果接近替尔泊肽，GZR18和ZT002接近三靶点 - 2025年06月 - 行业研究数据 - 小牛行研
